Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|3|812-822

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.3, 2015-03, pp. : 812-822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Hyaluronan as a Marker of Liver Fibrosis in Hemophiliacs with Hepatitis C Virus-Associated Chronic Liver Disease

By  

Acta Haematologica, Vol. 99, Iss. 4, 1998-05 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Host genetic variations associated with disease progression in chronic hepatitis C virus infection

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 2, 2018-02 ,pp. : 127-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1054-1062

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum protein isoform profiles indicate the progression of hepatitis C virus-induced liver diseases

By                    

International Journal of Molecular Medicine, Vol. 31, Iss. 4, 2013-01 ,pp. : 943-950

Spandidos Publications

Access to resources Recommend Favorite